Materialise is a world leading 3D printing solutions provider, is working with partners to remove uncertainty and confusion for hospitals and physicians who are incorporating additive manufacturing into their diagnostic and surgical planning processes.
The company has launched a certification program that allows printer manufacturers that partner with the company to have products tested and validated as being fully compatible with Materialise Mimics inPrint software. inPrint is the first and only software to gain clearance from the FDA to develop 3D printed anatomical models for diagnostic and surgical planning uses. The inPrint software is printer- and material-agnostic, allowing Materialise to develop partnerships and solutions to meet a range of hospital and clinician requirements.
Materialise is working to address potential challenges for health care providers by ensuring their 3D operations are fully compatible and able to meet quality standards for developing and printing patient-specific 3D anatomical models. As the backbone of the additive manufacturing industry, Materialise incorporates nearly three decades of 3D printing experience and expertise to help medical professionals deliver more personalized patient care.
Stratasys and Ultimaker are the first two additive manufacturing hardware partners to participate in this program and to have their products tested by Materialise to certify compatibility.